Cyclic adenosine 3′,5′-monophosphate in rat steatotic liver transplantation

Liver Transplantation

Volumn 17, Issue 9, 2011, Pages 1099-1110

  Jimenez Castro, Monica B ^a   Casillas Ramirez, Arani ^a   Massip Salcedo, Marta ^a,b   Elias Miro, Maria ^a   Serafin, Anna ^c   Rimola, Antoni ^a,b,d   Rodes, Juan ^a,b,d   Peralta, Carmen ^a,b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Platform of Laboratory Animal Applied Research   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE ACTIVATOR; ADENYLATE CYCLASE INHIBITOR; BUCLADESINE; CYCLIC AMP; FORSKOLIN; FRUCTOSE 6 PHOSPHATE; GLUCOSE 6 PHOSPHATE; GLUTATHIONE; HYALURONIC ACID; LACTIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SUPEROXIDE DISMUTASE; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FATTY LIVER; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; MICROSCOPY; NONHUMAN; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RAT; SURVIVAL RATE; TREATMENT OUTCOME; WESTERN BLOTTING;

ANIMALS; CYCLIC AMP; FATTY LIVER; HOMOZYGOTE; HYALURONIC ACID; ISCHEMIA; ISCHEMIC PRECONDITIONING; LIVER; LIVER TRANSPLANTATION; OXIDATIVE STRESS; RATS; RATS, ZUCKER; TIME FACTORS; TRANSAMINASES; TYROSINE;

EID: 80052006790     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22359     Document Type: Article

References (61)

1. D'Alessandro AM, Kalayoglu M, Sollinger HW, Hoffmann RM, Reed A, Knechtle SJ, et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991; 51: 157-163.
2. Ploeg RJ, D'Alessandro AM, Knechtle ST, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 1993; 55: 807-813. (Pubitemid 23122053)
3. Mei FC, Qiao J, Tsygankova OM, Meinkoth JL, Quilliam LA, Cheng X,. Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation. J Biol Chem 2002; 277: 11497-11504. (Pubitemid 34952919)
4. Minor T, Akbar S, Yamamoto Y,. Adenosine A2 receptor stimulation protects the predamaged liver from cold preservation through activation of cyclic adenosine monophosphate-protein kinase A pathway. Liver Transpl 2000; 6: 196-200. (Pubitemid 30174000)
5. Akbar S, Minor T,. Significance and molecular targets of protein kinase A during cAMP-mediated protection of cold stored liver grafts. Cell Mol Life Sci 2001; 58: 1708-1714. (Pubitemid 32996105)
6. Tomita I, Sawa M, Munakata T, Tanaka K, Kasai S,. The beneficial effect of dibutyryl cyclic adenosine monophosphate on warm ischemic injury of the rat liver induced by cardiac arrest. Transplantation 1996; 62: 167-173. (Pubitemid 26251279)
7. Van Ness K, Podkameni D, Schwartz M, Boros P, Miller C,. Dibutyryl cAMP reduces nonparenchymal cell damage during cold preservation of rat livers. J Surg Res 1995; 58: 728-731.
8. Takei K, Tokuyama K, Kato M, Morikawa A,. Role of cyclic adenosine monophosphate in reducing superoxide anion generation in guinea pig alveolar macrophages. Pharmacology 1998; 57: 1-7. (Pubitemid 28288862)
9. Chaves MM, Costa DC, Souza DA, Lima e Silva FC, Machado JA,. Correlation between ROS production and InsP3 released by granulocytes from type 1 diabetic patients in a cAMP-dependent manner. Curr Aging Sci 2008; 1: 51-55.
10. Nogueira-Machado JA, Lima e Silva FC, Cunha EP, Calsolari MR, Costa DC, Perilo CS, et al. Modulation of the production of reactive oxygen species (ROS) by cAMP-elevating agents in granulocytes from diabetic patients: an Akt/PKB-dependent phenomenon. Diabetes Metab 2006; 32: 331-335. (Pubitemid 44410146)
11. Ishikawa H, Jin MB, Ogata T, Taniguchi M, Suzuki T, Shimamura T, et al. Role of cyclic nucleotides in ischemia and reperfusion injury of canine livers. Transplantation 2002; 73: 1041-1048. (Pubitemid 34415432)
12. Minor T, Akbar S,. Enhancement of endogenous cyclic AMP signal: a new approach to allow for cold preservation of rat livers from non-heart-beating donors? Transplantation 1998; 66: 990-994. (Pubitemid 28513375)
13. Carrasco-Chaumel E, Rosellõ-Catafau J, Bartrons R, Franco-Gou R, Xaus C, Casillas A, et al. Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. J Hepatol 2005; 43: 997-1006. (Pubitemid 41627985)
14. Arai M, Thurman RG, Lemasters JJ,. Contribution of adenosine A(2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers. Hepatology 2000; 32: 297-302. (Pubitemid 30614662)
15. Alfany-Fernandez I, Casillas-Ramirez A, Bintanel-Morcillo M, Brosnihan KB, Ferrario CM, Serafin A, et al. Therapeutic targets in liver transplantation: angiotensin II in nonsteatotic grafts and angiotensin-(1-7) in steatotic grafts. Am J Transplant 2009; 9: 439-451.
16. Selzner M, Rüdiger HA, Sindram D, Madden J, Clavien PA,. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 2000; 32: 1280-1288.
17. Kamada N, Calne RY,. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28: 47-50. (Pubitemid 9229718)
18. Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999; 104: 1631-1639. (Pubitemid 30002375)
19. Peralta C, Bartrons R, Riera L, Manzano A, Xaus C, Gelpí E, Rosellõ-Catafau J,. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol 2000; 279: G163-G171. (Pubitemid 30612695)
20. Tolliver BK, Ho LB, Fox LM, Berger SP,. Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine. J Pharmacol Exp Ther 1999; 289: 38-47. (Pubitemid 29156010)
21. Avendano CE, Billman GE,. Effect of interventions that increase cyclic AMP levels on susceptibility to ventricular fibrillation in unanesthetized dogs. Eur J Pharmacol 1994; 255: 99-109. (Pubitemid 24105749)
22. Franco-Gou R, Peralta C, Massip-Salcedo M, Xaus C, Serafín A, Rosellõ-Catafau J,. Protection of reduced-size liver for transplantation. Am J Transplant 2004; 4: 1408-1420. (Pubitemid 39159055)
23. Yin DP, Sankary HN, Chong AS, Ma LL, Shen J, Foster P, Williams JW,. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998; 66: 152-157. (Pubitemid 28369992)
24. Peralta C, Bartrons R, Serafin A, Blázquez C, Guzmán M, Prats N, et al. Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology 2001; 34: 1164-1173. (Pubitemid 33096589)
25. Peralta C, Rull R, Rimola A, Deulofeu R, Rosellõ-Catafau J, Gelpí E, Rodés J,. Endogenous nitric oxide and exogenous nitric oxide supplementation in hepatic ischemia-reperfusion injury in the rat. Transplantation 2001; 71: 529-536. (Pubitemid 32207204)
26. Peralta C, Hotter G, Closa D, Prats N, Xaus C, Gelpí E, Rosellõ-Catafau J,. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 1999; 29: 126-132. (Pubitemid 29023994)
27. Hortelano S, Genaro AM, Boscá L,. Phorbol esters induce nitric oxide synthase activity in rat hepatocytes. Antagonism with the induction elicited by lipopolysaccharide. J Biol Chem 1992; 267: 24937-24940.
28. Serafín A, Rosellõ-Catafau J, Prats N, Xaus C, Gelpí E, Peralta C,. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002; 161: 587-601. (Pubitemid 36142167)
29. Greenacre SA, Evans P, Halliwell B, Brain SD,. Formation and loss of nitrated proteins in peroxynitrite-treated rat skin in vivo. Biochem Biophys Res Commun 1999; 262: 781-786. (Pubitemid 29443735)
30. Peralta C, Bulbena O, Bargallõ R, Prats N, Gelpí E, Rosellõ-Catafau J,. Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion. Transplantation 2000; 70: 1761-1770.
31. Vázquez-Gil MJ, Mesonero MJ, Flores O, Criado M, Hidalgo F, Arévalo MA, et al. Sequential changes in redox status and nitric oxide synthases expression in the liver after bile duct ligation. Life Sci 2004; 75: 717-732. (Pubitemid 38686702)
32. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Thomas P, Dannenberg AJ,. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. Am J Physiol Gastrointest Liver Physiol 2003; 284: G321-G327. (Pubitemid 36120138)
33. Hsle AW, Kawashima K, O'Neill JP, Schröder CH,. Possible role of adenosine cyclic 3':5'-monophosphate phosphodiesterase in the morphological transformation of Chinese hamster ovary cells mediated by N6,O2-dibutyryl adenosine cyclic 3':5'-monophosphate. J Biol Chem 1975; 250: 984-989.
34. O'Neill JP, Schröder CH, Hsle AW,. Hydrolysis of butyryl derivatives of adenosine cyclic 3':5'-monophosphate by Chinese hamster ovary cell extracts and characterization of the products. J Biol Chem 1975; 250: 990-995.
35. Sandhu R, Thomas U, Diaz RJ, Wilson GJ,. Effect of ischemic preconditioning of the myocardium on cAMP. Circ Res 1996; 78: 137-147. (Pubitemid 26004130)
36. Hers HG, Hue L,. Gluconeogenesis and related aspects of glycolysis. Annu Rev Biochem 1983; 52: 617-653. (Pubitemid 13030690)
37. Stamler JS,. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994; 78: 931-936. (Pubitemid 24292322)
38. Beckman JS, Koppenol WH,. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271 (pt 1): C1424-C1437.
39. Grisham MB, Jourd'Heuil D, Wink DA,. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol 1999; 276 (pt 1): G315-G321. (Pubitemid 29104144)
40. Nogueira-Machado JA, Lima e Silva FC, Medina LO, Costa DC, Chaves MM,. Modulation of the reactive oxygen species (ROS) generation mediated by cyclic AMP-elevating agents or interleukin 10 in granulocytes from type 2 diabetic patients (NIDDM): a PKA-independent phenomenon. Diabetes Metab 2003; 29: 533-537. (Pubitemid 37474266)
41. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG,. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 1997; 33: 243-257. (Pubitemid 27072627)
42. Neely JR, Grotyohann LW,. Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts. Circ Res 1984; 55: 816-824. (Pubitemid 15180282)
43. Caplan MS, Hedlund E, Hill N, MacKendrick W,. The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats. Gastroenterology 1994; 106: 346-352. (Pubitemid 24041210)
44. Kobayashi H, Nonami T, Kurokawa T, Takeuchi Y, Harada A, Nakao A, Takagi H,. Role of endogenous nitric oxide in ischemia-reperfusion injury in rat liver. J Surg Res 1995; 59: 772-779. (Pubitemid 26013902)
45. Williams MW, Taft CS, Ramnauth S, Zhao ZQ, Vinten-Johansen J,. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc Res 1995; 30: 79-86.
46. Fernández L, Carrasco-Chaumel E, Serafín A, Xaus C, Grande L, Rimola A, et al. Is ischemic preconditioning a useful strategy in steatotic liver transplantation? Am J Transplant 2004; 4: 888-899. (Pubitemid 38745587)
47. Jaeschke H, Schini VB, Farhood A,. Role of nitric oxide in the oxidant stress during ischemia/reperfusion injury of the liver. Life Sci 1992; 50: 1797-1804.
48. Lõpez-Neblina F, Paez AJ, Toledo AH, Toledo-Pereyra LH,. Role of nitric oxide in ischemia/reperfusion of the rat kidney. Circ Shock 1994; 44: 91-95.
49. Moncada S, Erusalimsky JD,. Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat Rev Mol Cell Biol 2002; 3: 214-220.
50. Ferdinandy P, Schulz R,. Nitric oxide, superoxide and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 2003; 138: 532-543. (Pubitemid 36315301)
51. MacMillan-Crow LA, Crow JP, Thompson JA,. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 1998; 37: 1613-1622. (Pubitemid 28093677)
52. Mustafa SB, Olson MS,. Expression of nitric-oxide synthase in rat Kupffer cells is regulated by cAMP. J Biol Chem 1998; 273: 5073-5080. (Pubitemid 28108666)
53. Zhang XP, Hintze TH,. cAMP signal transduction induces eNOS activation by promoting PKB phosphorylation. Am J Physiol Heart Circ Physiol 2006; 290: H2376-H2384. (Pubitemid 43846065)
54. Nogueira-Machado JA, Lima E Silva FC, Lima E Silva R, Medina LO, Costa DC, Chaves MM,. Effect in vitro of cyclic nucleotides-elevating agents on nitric oxide production by human granulocytes from type 2-diabetic patients. Diabetes Metab 2002; 28: 45-50. (Pubitemid 34168750)
55. Isoni CA, Borges EA, Veloso CA, Mattos RT, Chaves MM, Nogueira-Machado JA,. cAMP activates the generation of reactive oxygen species and inhibits the secretion of IL-6 in peripheral blood mononuclear cells from type 2 diabetic patients. Oxid Med Cell Longev 2009; 2: 317-321.
56. Jaeschke H,. Xanthine oxidase-induced oxidant stress during hepatic ischemia-reperfusion: are we coming full circle after 20 years? Hepatology 2002; 36: 761-763. (Pubitemid 34977190)
57. Nagayama M, Katsuramaki T, Kimura H, Isobe M, Meguro M, Matsuno T, et al. Prediction of graft viability from non-heart-beating donor pigs using hepatic microdialysate hypoxanthine levels. J Surg Res 2002; 107: 210-218. (Pubitemid 35379661)
58. Harvey PR, Iu S, McKeown CM, Petrunka CN, Ilson RG, Strasberg SM,. Adenine nucleotide tissue concentrations and liver allograft viability after cold preservation and warm ischemia. Transplantation 1988; 45: 1016-1020.
59. Net M, Valero R, Almenara R, Rull R, Gonzalez FJ, Taurá P, et al. Hepatic xanthine levels as viability predictor of livers procured from non-heart-beating donor pigs. Transplantation 2001; 71: 1232-1237. (Pubitemid 32507140)
60. Noel AA, Hobson RW II, Durán WN,. Platelet-activating factor and nitric oxide mediate microvascular permeability in ischemia-reperfusion injury. Microvasc Res 1996; 52: 210-220. (Pubitemid 26423286)
61. Verrier E,. The microvascular cell and ischemia-reperfusion injury. J Cardiovasc Pharmacol 1996; 27 (suppl 1): S26-S30. (Pubitemid 26061487)